Back to All
Group

Podcast: Oncology Patient Research

9 August, 2018

Why do we need to talk biomarkers with patients?

Senior Director of Market Research at Diaceutics, Marianne Fillion, recently spearheaded an effort to gather insights directly from oncology patients to get an understanding of what they know about biomarkers and diagnostic testing, where they look for information and what gaps they feel need to be addressed to better arm them with the right details about their conditions, diagnostics and treatment options. Following presentation of these results at the Intellus Worldwide Summit 2018, she discusses the key findings with Managing Director of Marketing, Steve Vitale.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.